Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recombinant Factor VIIa (rFVIIa) for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial

NCT03496883 is registered in ClinicalTrials.gov with Joseph Broderick, MD as lead sponsor.

NCT NCT03496883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03496883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recombinant Factor VIIa (rFVIIa) for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial
Lead sponsor
Joseph Broderick, MD
Phase
Phase 3
Overall status
Active, not recruiting
Start date
December 3, 2021
Completion date
January 1, 2028
Enrollment
860 (estimated)
Sites
88

Conditions

As the registry lists them; a condition with its own page is linked.

intracerebral hemorrhage